Agency for Disease Control and Prevention “Case of death, low association with the vaccine” … Continue vaccination



[ad_1]

Disease management, 26 deaths after vaccination “low direct causation”
Judge that the situation is not a new test or suspension of the vaccine
Voices from medical reserves are loud and ‘anxious vaccination’ is expected to continue

Amid reports of death after being vaccinated against influenza (flu), a notice to suspend influenza vaccination was posted at a Seoul hospital on the afternoon of the 23rd. News 1

Health officials have decided to continue vaccination against influenza (flu). This is because the association with the vaccine was found to be very low as a result of the autopsy-based judgment of death after vaccination. However, by day 23, there were as many as 40 cases of death after vaccination (36 cases at 1 pm), and national discontent over the flu vaccine continues to rise, with some medical circles recommending stopping vaccination for one week. It is expected to continue.

On the 23rd, the Korea Centers for Disease Control and Prevention said, “As a result of a comprehensive review of the side effects of the flu and the possibility of death from underlying diseases, the Immunization Harm Research Team at In 26 cases of death, direct causality between death and vaccination was considered very low. ” “Therefore, the damage investigation team recommended continuing the vaccination business.” The Vaccination Harm Investigation Team held the third meeting on this day and discussed △ whether there was an adverse reaction to the vaccine, △ re-evaluation of the vaccine vaccinated by the deceased, △ the need to stop vaccination, etc. for 26 cases of death reported until the previous day.

First, it was concluded that no case of “anaphylaxis shock” was suspected, a typical side effect of vaccination. Anaphylaxis is a serious allergic reaction that occurs throughout the body and symptoms appear acutely within 24 hours after vaccination.

In addition, it was determined that there was no situation to retest or stop using the vaccine. The Agency for Disease Control and Prevention said: “If two or more serious adverse reactions that cannot be excluded from direct causation of vaccination in the same vaccine serial number, we plan to review or discontinue use.” Of the reported deaths, four vaccines with the same serial number each were vaccinated, but it is unlikely that they all died due to the side effects of vaccination, so it cannot be considered a problem with the vaccine itself.

Interim autopsy results for 20 death cases were also reported. Of the 20 cases, 13 deaths were found to have cardiovascular disease (8 cases) and cerebrovascular disease (2 cases) and others (3 cases), confirming that vaccination and causation were not present. The remaining seven are undergoing further testing. Of the 6 cases that did not undergo autopsy, 4 cases concluded that there was no cause of vaccination and causality for death due to disease (3 cases) and asphyxia (1 case).

The Agency for Disease Control and Prevention said that the causal relationship between vaccination and death is low, and that vaccination against influenza will continue to reduce the risk of a new coronavirus infection (Corona 19) and the simultaneous outbreak of influenza.

However, there is no possibility that the ongoing vaccination policy will change. The Agency for Disease Control and Prevention held a committee of vaccination experts that day to discuss influenza vaccination and will revisit additional analysis data on the morning of the 24th to review future vaccination plans. The harm investigation team recommended continuing vaccination based on the fact that the causal relationship between the vaccine and death is low, but the expert committee on vaccination comprehensively judges people’s anxiety.

Nam Bora reporter




Subscribe to the Hankook Ilbo News Naver channel
Subscribe at Play Kiosco

Balance to see the world, the Hankook Ilbo Copyright © Hankookilbo



[ad_2]